01 42Care4 Aps
02 12care4 ApS
03 3Amphastar France Pharmaceuticals
04 1Amphastar France Pharmaceuticals Plant Saint-Charles
05 1Amphastar France Pharmaceuticals Sas
06 1Central Procurement & Supplies Unit
07 1Future Health Pharma Gmbh
08 2NOVO NORDISK A/S
09 3Novo Nordisk A/S
10 1Novo Nordisk Pharma Ag
11 2NovoNordisk A/S
12 1Orifarm A/S
13 1Orifarm AS
14 1Pharmachim Ab
15 1Strongbridge Dublin Limited
16 8Tetris Pharma B.V.
17 4Tetris Pharma Bv
01 25Glucagon
02 6Glucagon Hydrochloride
03 1Glucagon Rdna
04 4Glukagon
01 2Glucagon 1Mg 1 Unit Parenteral Use
02 5Inhalation Powder
03 1Injectable Solution
04 3Nasal Powder In Single-Dose Container
05 3Powder And Solvent For Injection Solution
06 2Powder And Solvents For Solution For Injection
07 20Solution For Injection
01 7Denmark
02 6Estonia
03 2Italy
04 3Malta
05 4Norway
06 1Spain
07 11Sweden
08 2Switzerland
01 8Baqsimi
02 1GlucaGen Novo
03 2Glucagen
04 1Glucagen 1Mg Hypokit
05 1Glucagen Hypo
06 3Glucagen Hypokit
07 1Glucagen/Glucagen Hypokit
08 6Glucagon Novo Nordisk
09 13Ogluo
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Inhalation Powder
Dosage Strength : 3mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Glucagen Hypokit
Dosage Form : Powder And Solvents For Solution For Injection
Dosage Strength :
Packaging :
Approval Date : 04-06-2013
Application Number : 28105228613
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Glucagon Novo Nordisk
Dosage Form : Solution For Injection
Dosage Strength : 1mg(1IU)
Packaging :
Approval Date : 22-04-2015
Application Number : 2.01E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Glucagon Novo Nordisk
Dosage Form : Solution For Injection
Dosage Strength : 1mg(1IU)
Packaging :
Approval Date : 22-04-2015
Application Number : 2.01E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Glucagon Novo Nordisk
Dosage Form : Solution For Injection
Dosage Strength : 1mg(1IU)
Packaging :
Approval Date : 22-04-2015
Application Number : 2.01E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Inhalation Powder
Dosage Strength : 3mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Baqsimi
Dosage Form : Nasal Powder In Single-Dose Container
Dosage Strength : 3mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Baqsimi
Dosage Form : Nasal Powder In Single-Dose Container
Dosage Strength : 3MG
Packaging :
Approval Date : 17-01-2020
Application Number : 1191406001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Baqsimi
Dosage Form : Nasal Powder In Single-Dose Container
Dosage Strength : 3mg
Packaging :
Approval Date : 16-12-2019
Application Number : 28106149818
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Baqsimi
Dosage Form : Inhalation Powder
Dosage Strength :
Packaging :
Approval Date : 16-12-2019
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
